Metastatic melanoma: changes in epidemiology and current standards of care (1/6)

Share :
Published: 15 Aug 2011
Views: 8026
European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf
Given the trend of increasing incidence of malignant melanoma, there is a continuing need for improvements in the treatment options. The panel discuss the current standard of care, emphasising the important role of surgery for eligible patients, outline prognostic factors and talk about recent trials investigating therapies such as dacarbazine.